241 related articles for article (PubMed ID: 33767379)
21. Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability.
Zhao T; Meng Q; Sun Z; Chen Y; Ai W; Zhao Z; Kang D; Dong Y; Liang R; Wu T; Pang J; Liu X; Zhan P
J Med Chem; 2020 Oct; 63(19):10829-10854. PubMed ID: 32897699
[TBL] [Abstract][Full Text] [Related]
22. Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor.
Cai W; Wu J; Liu W; Xie Y; Liu Y; Zhang S; Xu W; Tang L; Wang J; Zhao G
Molecules; 2018 Jan; 23(2):. PubMed ID: 29382075
[TBL] [Abstract][Full Text] [Related]
23. Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes.
Zhang B; Duan M; Long B; Zhang B; Wang D; Zhang Y; Chen J; Huang X; Jiao Y; Zhu L; Zeng X
Mol Med Rep; 2019 Aug; 20(2):1645-1654. PubMed ID: 31257523
[TBL] [Abstract][Full Text] [Related]
24. Overview of the pharmacokinetics and pharmacodynamics of URAT1 inhibitors for the treatment of hyperuricemia and gout.
Hou Z; Ma A; Mao J; Song D; Zhao X
Expert Opin Drug Metab Toxicol; 2023 Dec; 19(12):895-909. PubMed ID: 37994776
[TBL] [Abstract][Full Text] [Related]
25. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
[TBL] [Abstract][Full Text] [Related]
26. Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.
Wu XH; Ruan JL; Zhang J; Wang SQ; Zhang YW
J Ethnopharmacol; 2014 Nov; 157():201-5. PubMed ID: 25267580
[TBL] [Abstract][Full Text] [Related]
27. Paeonia × suffruticosa Andrews leaf extract and its main component apigenin 7-O-glucoside ameliorate hyperuricemia by inhibiting xanthine oxidase activity and regulating renal urate transporters.
Zhang Y; Li Y; Li C; Zhao Y; Xu L; Ma S; Lin F; Xie Y; An J; Wang S
Phytomedicine; 2023 Sep; 118():154957. PubMed ID: 37478683
[TBL] [Abstract][Full Text] [Related]
28. Fucoidan from
Zhang Y; Tan X; Lin Z; Li F; Yang C; Zheng H; Li L; Liu H; Shang J
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922488
[TBL] [Abstract][Full Text] [Related]
29. Identification and characterization of a potent and selective inhibitor of human urate transporter 1.
Wu T; Chen J; Dong S; Li H; Cao Y; Tian Y; Fu W; Zhou P; Xi B; Pang J
Pharmacol Rep; 2017 Oct; 69(5):1103-1112. PubMed ID: 28988709
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and activity evaluation of novel lesinurad analogues containing thienopyrimidinone or pyridine substructure as human urate transporter 1 inhibitors.
Zhang J; Dong Y; Gao S; Zhang X; Liao H; Shi X; Zhang Z; Zhao T; Liang R; Qi D; Wu T; Pang J; Liu X; Zhan P
Eur J Med Chem; 2022 Dec; 244():114816. PubMed ID: 36219903
[TBL] [Abstract][Full Text] [Related]
31. [Uric Acid Metabolism, Uric Acid Transporters and Dysuricemia].
Ichida K
Yakugaku Zasshi; 2024; 144(6):659-674. PubMed ID: 38825475
[TBL] [Abstract][Full Text] [Related]
32. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).
Dong Y; Zhao T; Ai W; Zalloum WA; Kang D; Wu T; Liu X; Zhan P
Expert Opin Ther Pat; 2019 Nov; 29(11):871-879. PubMed ID: 31593642
[No Abstract] [Full Text] [Related]
33. Discovery of a Novel Thienopyrimidine Compound as a Urate Transporter 1 and Glucose Transporter 9 Dual Inhibitor with Improved Efficacy and Favorable Druggability.
Shi X; Zhao T; Wang S; Xu S; Liao H; Gao S; Gao Z; Zhang J; Qi D; Zhang Z; Zheng F; Wang Y; Wang Z; Yang M; Yang Q; Yi F; Pang J; Liu X; Zhan P
J Med Chem; 2024 Mar; 67(6):5032-5052. PubMed ID: 38482820
[TBL] [Abstract][Full Text] [Related]
34. Saponins extracted from Dioscorea collettii rhizomes regulate the expression of urate transporters in chronic hyperuricemia rats.
Zhu L; Dong Y; Na S; Han R; Wei C; Chen G
Biomed Pharmacother; 2017 Sep; 93():88-94. PubMed ID: 28624426
[TBL] [Abstract][Full Text] [Related]
35. Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.
Hamada T; Ichida K; Hosoyamada M; Mizuta E; Yanagihara K; Sonoyama K; Sugihara S; Igawa O; Hosoya T; Ohtahara A; Shigamasa C; Yamamoto Y; Ninomiya H; Hisatome I
Am J Hypertens; 2008 Oct; 21(10):1157-62. PubMed ID: 18670416
[TBL] [Abstract][Full Text] [Related]
36. Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3.
Yong T; Liang D; Chen S; Xiao C; Gao X; Wu Q; Xie Y; Huang L; Hu H; Li X; Liu Y; Cai M
Phytomedicine; 2022 Aug; 103():154256. PubMed ID: 35714456
[TBL] [Abstract][Full Text] [Related]
37. Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.
Mancikova A; Krylov V; Hurba O; Sebesta I; Nakamura M; Ichida K; Stiburkova B
Clin Exp Nephrol; 2016 Aug; 20(4):578-584. PubMed ID: 26500098
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout.
Wu JW; Yin L; Liu YQ; Zhang H; Xie YF; Wang RL; Zhao GL
Bioorg Med Chem Lett; 2019 Feb; 29(3):383-388. PubMed ID: 30579795
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
[TBL] [Abstract][Full Text] [Related]
40. The effect of testosterone upon the urate reabsorptive transport system in mouse kidney.
Hosoyamada M; Takiue Y; Shibasaki T; Saito H
Nucleosides Nucleotides Nucleic Acids; 2010 Jul; 29(7):574-9. PubMed ID: 20589576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
